Blue Jet Healthcare Reports Strong Financial Growth and Record Sales in July 2025
Blue Jet Healthcare has reported strong financial results for the quarter ending June 2025, with a Profit After Tax of Rs 201.27 crore, reflecting significant year-on-year growth. The company also achieved record quarterly net sales of Rs 354.76 crore, indicating robust demand for its products and improved profitability.
Blue Jet Healthcare, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on July 22, 2025, indicate a notable performance during this period.The company achieved a Profit After Tax (PAT) of Rs 201.27 crore, reflecting a significant year-on-year growth of 159.94%. This upward trend in PAT underscores the company's strong operational capabilities. Additionally, Blue Jet Healthcare recorded its highest quarterly net sales at Rs 354.76 crore, marking a growth of 37.8% compared to the average net sales of the previous four quarters, which stood at Rs 257.50 crore. This consistent increase in sales over the last five quarters highlights a robust demand for the company's offerings.
Furthermore, the Profit Before Tax (PBT), excluding other income, reached Rs 114.61 crore, showing a growth of 27.4% against the average PBT of Rs 89.96 crore from the previous four quarters. These figures suggest a favorable trend in profitability for Blue Jet Healthcare.
In light of these developments, the stock has experienced adjustments in its evaluation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
